Lexogen, a Vienna-based biotech company specialized in RNA transcriptomics technologies and services announces the completion ...

Thiruvananthapuram: In a significant national recognition, the Kerala capital city-based Rajiv Gandhi Centre for ...

In a significant recognition of its scientific expertise, the Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB) has been selected as one of four national hubs for Next-Generation Sequencing (NGS) ...

Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...

Poster presentation highlights promising results from Phase 1b/2 TENACITY-01 study of CTD402 in T-Cell and myeloid leukemiasFindings underscore ...

The 24th HUPO World Congress showed a field growing beyond mass spectrometry and starting to think in terms of impact of its ecosystems.

The Rajiv Gandhi Centre for Biotechnology (RGCB) has been selected as one of the four national next-generation sequencing (NGS) hubs for the Metagenomic Syndromic Surveillance Programme under the ...

Expanded newborn genetic screening can diagnose hundreds of actionable conditions, allowing for earlier treatment.

Devyser today announced the enrollment of the first patient in its Devyser Accept cfDNA clinical trial, a key milestone in the company's efforts to bring a targeted next-generation sequencing solution ...

While traditional methods like blood tests and microscopic examination remain important, modern technology offers far greater ...

For Professor Tulio de Oliveira, being a world-renowned scientist is a dream he’s had since he was a 10-year-old boy, and one ...